Nasus Pharma Ltd. (NSRX)

Profile

Full Name

Nasus Pharma Ltd.

Ticker

NYSEAmerican: NSRX

Exchange

NYSE American

Sector

Healthcare

Industry

General Drug Manufacturers

Country

Israel

IPO

August 13, 2025

Indexes

Not included

Website

https://www.nasuspharma.com

Employees

1

Key Details

Price

$7.98(-0.39%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $7.98
    NSRX price is $7.98

    30-Day Relative Volume

    0.41
    NSRX 30-day relative volume is 0.41

    Price Performance

    Price Most recent change

    -0.39%
    NSRX price was down -0.39% on Sep 5, 2025

    Price YTD change

    -
    NSRX price ytd change is unknown

    Price 1-year change

    -
    NSRX price 1-year change is unknown

    Price 3-year change

    -
    NSRX price 3-year change is unknown

    Price Range

    Price All-time high

    $9.99
    NSRX price is currently -20.12% below its historical high of $9.99

    Price 3-year low

    $7.23
    NSRX price is currently +10.37% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $72.30M
    NSRX market capitalization is $72.30 million

    Market cap 3-year change

    -
    NSRX market capitalization 3-year change is unknown

    Market cap All-time high

    $78.73M
    NSRX market capitalization is currently -8.17% below its historical high of $78.73 million

    Market cap sector rank

    36.86%
    NSRX market capitalization is higher than 36.86% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -
    NSRX shares outstanding 1-year change is unknown

    Shares Outstanding 3-Year Change

    -
    NSRX shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -1.09
    NSRX beta is -1.09

    200-day SMA

    $8.17
    NSRX price is currently -2.38% below its 200-day simple moving average

    50-day SMA

    $8.17
    NSRX price is currently -2.38% below its 50-day simple moving average

    RSI

    40.88
    NSRX 14-day relative strength index is 40.88

    Volume

    0.41
    NSRX 30-day relative volume is 0.41

    ATR

    $0.46
    NSRX average true range is $0.46

    10-day Historical Volatility

    23.33%
    NSRX 10-day historical volatility is 23.33%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    NSRX annual revenue is $0.00

    Revenue Analysts estimate

    -
    NSRX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    NSRX annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    NSRX annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -
    NSRX annual earnings per share value is unknown

    EPS Analysts estimate

    -
    NSRX annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -
    NSRX annual earnings per share 1-year change is unknown

    EPS Sector rank

    -
    NSRX annual earnings per share is unknown

    Profit

    Gross profit

    -
    NSRX annual gross profit value is unknown

    Gross margin

    -
    NSRX annual gross profit margin value is unknown

    Operating profit

    -$1.08M
    NSRX annual operating income is -$1.08 million

    Operating margin

    -
    NSRX annual operating profit margin value is unknown

    Net income

    -$1.53M
    NSRX annual net profit is -$1.53 million

    Net margin

    -
    NSRX annual net profit margin value is unknown

    Expenses

    Total expenses

    $1.08M
    NSRX annual total expenses is $1.08 million

    Operating expenses

    $1.08M
    NSRX annual total operating expenses is $1.08 million

    Cost of goods sold

    -
    NSRX annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $743.00K
    NSRX annual SGA is $743.00 thousand

    Depreciation and amortization

    -
    NSRX annual depreciation & amortization value is unknown

    Interest expense

    $29.00K
    NSRX annual interest expense is $29.00 thousand

    Income tax

    -
    NSRX annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$1.52M
    NSRX annual earnings before interest & taxes is -$1.52 million

    EBITDA

    -$1.52M
    NSRX annual EBITDA is -$1.52 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $717.00K
    NSRX annual total assets is $717.00 thousand

    Non current assets

    $260.00K
    NSRX annual long term assets is $260.00 thousand

    Current assets

    $457.00K
    NSRX annual total current assets is $457.00 thousand

    Cash and cash equivalents

    $284.00K
    NSRX annual cash & cash equivalents is $284.00 thousand

    Accounts receivable

    -
    NSRX annual accounts receivable value is unknown

    Inventory

    -
    NSRX annual inventory value is unknown

    Liabilities

    Total liabilities

    $3.93M
    NSRX annual total liabilities is $3.93 million

    Long term liabilities

    $0.00
    NSRX annual total long term liabilities is $0.00

    Current liabilities

    $3.93M
    NSRX annual total current liabilities is $3.93 million

    Accounts payable

    $651.00K
    NSRX annual accounts payable is $651.00 thousand

    Debt

    Total debt

    $1.80M
    NSRX annual total debt is $1.80 million

    Total debt 1-year change

    -26.66%
    NSRX annual total debt is down -26.66% year-on-year

    Long term debt

    -
    NSRX annual long term debt value is unknown

    Short term debt

    $1.80M
    NSRX annual short term debt is $1.80 million

    Equity & Capital

    Shareholders equity

    -$3.21M
    NSRX annual stockholders equity is -$3.21 million

    Book value

    -$3.21M
    NSRX annual book value is -$3.21 million

    Retained earnings

    -$12.66M
    NSRX annual retained earnings is -$12.66 million

    Working capital

    -$3.47M
    NSRX annual working capital is -$3.47 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$661.00K
    NSRX annual cash flow from operations is -$661.00 thousand

    Cash from operations 1-year change

    +32.69%
    NSRX annual cash flow from operations is up +32.69% year-on-year

    Cash from investing

    -
    NSRX annual cash flow from investing activities value is unknown

    Cash from investing 1-year change

    -
    NSRX annual cash flow from investing activities 1-year change is unknown

    Cash from financing

    $770.00K
    NSRX annual cash flow from financing activities is $770.00 thousand

    Cash from financing 1-year change

    -27.01%
    NSRX annual cash flow from financing activities is down -27.01% year-on-year

    CAPEX

    CAPEX

    -
    NSRX annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    NSRX annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$665.00K
    NSRX annual free cash flow is -$665.00 thousand

    Free cash flow 1-year change

    +35.37%
    NSRX annual free cash flow is up +35.37% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    NSRX annual gross profit margin value is unknown

    Operating margin

    -
    NSRX annual operating profit margin value is unknown

    Net margin

    -
    NSRX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -213.67%
    NSRX annual return on assets is -213.67%

    ROE

    47.70%
    NSRX annual return on equity is 47.70%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    NSRX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    NSRX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -22.51
    NSRX price to book ratio is -22.51

    PB ratio Sector rank

    2.86%
    NSRX price to book ratio is higher than 2.86% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    NSRX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    NSRX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $73.81M
    NSRX enterprise value is $73.81 million

    Enterprise value Sector rank

    43.33%
    NSRX enterprise value is higher than 43.33% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -
    NSRX EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    NSRX EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.12
    NSRX annual current ratio is 0.12

    Quick ratio

    -
    NSRX annual quick ratio value is unknown

    Leverage

    Debt to equity

    -0.56
    NSRX annual debt to equity ratio is -0.56

    Interest coverage ratio

    -52.52
    NSRX annual interest coverage ratio is -52.52

    Risk & Stability

    Piotroski F-Score

    -
    NSRX piotroski f-score value is unknown

    Altman Z-Score

    -26.51
    NSRX altman z-score is -26.51

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with NSRX included

    Stocks below SMA 200
    Healthcare sector
    All stocks
    Ex Dividend dates calendar
    Small cap stocks
    Israeli stocks
    NYSE American Exchange Companies
    Stocks with low beta
    Drug Manufacturers
    • What is the ticker symbol for Nasus Pharma Ltd.?
    • Does Nasus Pharma Ltd. pay dividends?
    • What sector is Nasus Pharma Ltd. in?
    • What industry is Nasus Pharma Ltd. in?
    • What country is Nasus Pharma Ltd. based in?
    • When did Nasus Pharma Ltd. go public?
    • Is Nasus Pharma Ltd. in the S&P 500?
    • Is Nasus Pharma Ltd. in the NASDAQ 100?
    • Is Nasus Pharma Ltd. in the Dow Jones?
    • When does Nasus Pharma Ltd. report earnings?

    What is the ticker symbol for Nasus Pharma Ltd.?

    The ticker symbol for Nasus Pharma Ltd. is NYSEAmerican:NSRX

    Does Nasus Pharma Ltd. pay dividends?

    No, Nasus Pharma Ltd. does not pay dividends

    What sector is Nasus Pharma Ltd. in?

    Nasus Pharma Ltd. is in the Healthcare sector

    What industry is Nasus Pharma Ltd. in?

    Nasus Pharma Ltd. is in the General Drug Manufacturers industry

    What country is Nasus Pharma Ltd. based in?

    Nasus Pharma Ltd. is headquartered in Israel

    When did Nasus Pharma Ltd. go public?

    Nasus Pharma Ltd.'s initial public offering (IPO) was on August 13, 2025

    Is Nasus Pharma Ltd. in the S&P 500?

    No, Nasus Pharma Ltd. is not included in the S&P 500 index

    Is Nasus Pharma Ltd. in the NASDAQ 100?

    No, Nasus Pharma Ltd. is not included in the NASDAQ 100 index

    Is Nasus Pharma Ltd. in the Dow Jones?

    No, Nasus Pharma Ltd. is not included in the Dow Jones index

    When does Nasus Pharma Ltd. report earnings?

    The date for Nasus Pharma Ltd.'s next earnings report has not been announced yet
    On this page